{"id":"https://openalex.org/W7204704809","doi":"https://doi.org/10.1016/s2152-2650(26)03226-x","title":"CT-1436: Inpatient Outcomes of Cytokine Release Syndrome and ICANS Among CAR-T Hospitalizations in the United States: 2022\u20132023","display_name":"CT-1436: Inpatient Outcomes of Cytokine Release Syndrome and ICANS Among CAR-T Hospitalizations in the United States: 2022\u20132023","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204704809","doi":"https://doi.org/10.1016/s2152-2650(26)03226-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)03226-x","doi":"https://doi.org/10.1016/s2152-2650(26)03226-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)03226-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007703218","display_name":"Ashish Nepal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156405","display_name":"WellSpan York Hospital","ror":"https://ror.org/04r67yj20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210111146","https://openalex.org/I4210156405"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish Nepal","raw_affiliation_strings":["WellSpan York Hospital, York, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WellSpan York Hospital, York, PA, USA","institution_ids":["https://openalex.org/I4210156405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136382453","display_name":"Sapna Kumari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156405","display_name":"WellSpan York Hospital","ror":"https://ror.org/04r67yj20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210111146","https://openalex.org/I4210156405"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sapna Kumari","raw_affiliation_strings":["WellSpan York Hospital, York, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WellSpan York Hospital, York, PA, USA","institution_ids":["https://openalex.org/I4210156405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090898775","display_name":"Suhail Sapkota","orcid":"https://orcid.org/0000-0002-9310-0590","observed_orcids":["https://orcid.org/0000-0002-9310-0590"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suhail Sapkota","raw_affiliation_strings":["University of Michigan Health-Sparrow, Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health-Sparrow, Lansing, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5137190297","display_name":"Falah Abu Hassan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259572","display_name":"University of Arizona College of Medicine- Phoenix","ror":"https://ror.org/02drhvq25","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243","https://openalex.org/I4405259572"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Falah Abu Hassan","raw_affiliation_strings":["University of Arizona College of Medicine, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona College of Medicine, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4405259572"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S1282","last_page":"S1283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9049999713897705},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.8669999837875366},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8489999771118164},{"id":"https://openalex.org/keywords/in-hospital-outcomes","display_name":"hospitalization outcomes","score":0.8180000185966492},{"id":"https://openalex.org/keywords/in-hospital-mortality","display_name":"in-hospital mortality","score":0.9660000205039978},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.9350000023841858},{"id":"https://openalex.org/keywords/inpatient-charges","display_name":"inpatient charges","score":0.9169999957084656},{"id":"https://openalex.org/keywords/relapsed-refractory-hematologic-malignancies","display_name":"relapsed/refractory hematologic malignancies","score":0.921999990940094},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6669999957084656},{"id":"https://openalex.org/keywords/teaching-hospitals","display_name":"teaching hospitals","score":0.5680000185966492},{"id":"https://openalex.org/keywords/national-estimates","display_name":"national estimates","score":0.41499999165534973},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.4050000011920929},{"id":"https://openalex.org/keywords/healthcare-cost-and-utilization-project","display_name":"Healthcare Cost and Utilization Project","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.972599983215332},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4081000089645386},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.40310001373291016},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.3610000014305115},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3395000100135803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32829999923706055},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.27799999713897705},{"id":"https://openalex.org/C2781090800","wikidata":"https://www.wikidata.org/wiki/Q776030","display_name":"Systemic inflammatory response syndrome","level":3,"score":0.2721000015735626},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.23770000040531158},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.225600004196167}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)03226-x","doi":"https://doi.org/10.1016/s2152-2650(26)03226-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)03226-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281839888","https://openalex.org/W4417016991","https://openalex.org/W7108479590","https://openalex.org/W4410812841","https://openalex.org/W4409644288","https://openalex.org/W7204682208","https://openalex.org/W7162695604","https://openalex.org/W4413787834","https://openalex.org/W7162626822","https://openalex.org/W7127341895"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-31T00:00:00"}